Compare NBXG & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBXG | PLSE |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2016 |
| Metric | NBXG | PLSE |
|---|---|---|
| Price | $14.79 | $14.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | ★ 243.7K | 193.9K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 10.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $86,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,002.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.31 | $12.56 |
| 52 Week High | $12.23 | $25.00 |
| Indicator | NBXG | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 55.43 |
| Support Level | $14.37 | $13.17 |
| Resistance Level | $14.67 | $14.91 |
| Average True Range (ATR) | 0.22 | 0.78 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 93.43 | 59.50 |
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.